Global Peritoneal Dialysis Market

Global Peritoneal Dialysis Market

Strategic Analysis and Opportunity Assessment

GlobalData's 'Global Peritoneal Dialysis Market: Strategic Analysis and Opportunity Assessment' report is an essential source of data and analysis on the global peritoneal dialysis market. The report provides market landscape, competitive landscape and market trends information on the global peritoneal dialysis market. The report identifies the key trends shaping and driving the dynamism in the global peritoneal dialysis market. The report also provides insight on the prevalent competitive landscape and on the emerging players which are expected to bring significant shift in the market standing of the existing leaders. The report also analyses the M&A landscape with special focus on the market participants that have been the most M&A active. The report also provides valuable insight on the pipeline products within the global peritoneal dialysis market.

Scope

• The report provides market size data and information on the global peritoneal dialysis market.
• Annualized market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. Updated company shares data for 2008.
• Analysis and review of the key events and milestones that will impact the future of the global peritoneal dialysis market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these trends.
• Insightful review of key industry drivers, restraints and challenges which are likely to impact the global peritoneal dialysis market in the long run.
• In-depth analysis of the M&A landscape with a strong emphasis on the market players, likely to remain active in the near future.
• The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies. Key companies covered include Baxter, Fresenius, Gambro, B.Braun, Abbott and Medionics International Ltd
• Comprehensive analysis of the most likely developments expected to bring a shift to the market positions of the leading manufacturers.

Reasons to buy:

• Develop business strategies by understanding the trends shaping and driving the global peritoneal dialysis Market.
• Design and develop your product development, marketing and sales strategies by identifying the market categories poised for a strong growth.
• Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
• Identify key players best positioned to take advantage of the emerging market opportunities by developing insight on the prevalent and anticipated competitive landscape.
• Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global peritoneal dialysis market in future.
• Effectively plan your M&A and partnership strategies by identifying companies with the most promising pipeline.
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• What's the next being thing in the global peritoneal dialysis technology landscape? - Identify, understand and capitalize.

Contents

• 1 Table of contents
  • 1.1 List of Tables
  • 1.2 List of Figures
• 2 Disease Overview
  • 2.1 History of Peritoneal Dialysis
  • 2.2 End-Stage Renal Disease
  • 2.3 Glomerulonephritis
  • 2.4 Diabetes Accentuating Kidney Disease
    • 2.4.1 Global Prevalence of Diabetes
    • 2.4.2 Diabetes Prevalence in Developing Nations
• 3 Market Characterization
  • 3.1 Overview
  • 3.2 Peritoneal Dialysis Solutions, Revenue ($m), Global, Historic, 2000 –2008
  • 3.3 Peritoneal Dialysis Solutions, Revenue ($m), Global, Forecast, 2008–2015
  • 3.4 Peritoneal Dialysis Solutions, Revenue ($m), Cross Country Analysis, 2008
• 4 Market Dynamics
  • 4.1 Market Trends
    • 4.1.1 Increasing Uptake of Peritoneal Dialysis in Asian Economies
    • 4.1.2 Low Cost Equipment in Asia Increasing Uptake of Peritoneal Dialysis
    • 4.1.3 Increasing Reimbursement for Peritoneal Dialysis
    • 4.1.4 Positive Perception for Peritoneal Dialysis among Patients and Physicians
    • 4.1.5 Penetration of Peritoneal Dialysis
    • 4.1.6 Increasing Demand for Home Healthcare
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence of Diseases to Drive Growth
    • 4.2.2 Expanded Use in the Acute Care Setting
    • 4.2.3 Increasing Awareness to Boost the Peritoneal Dialysis Market
    • 4.2.4 Increasing Demand for Home Healthcare
  • 4.3 Market Restraints
    • 4.3.1 Overview
    • 4.3.2 Nasocomial Infections Post a Formidable Challenge for the Growth of PD
    • 4.3.3 The CANUSA Study
    • 4.3.4 Changes in the Peritoneal Membrane with Time
• 5 Competitive Landscape
  • 5.1 Overview
    • 5.1.1 Company Share Analysis
    • 5.1.2 Product Comparison
• 6 Pipeline Analysis
  • 6.1 CATHcarry
    • 6.1.1 Product Status
    • 6.1.2 Product Description
    • 6.1.3 CATHcarry Clinical Trial
  • 6.2 Next-Generation APD Cycler
    • 6.2.1 Product Status
    • 6.2.2 Product Description
  • 6.3 Non PVC CAPD
    • 6.3.1 Product Status
    • 6.3.2 Product Description
    • 6.3.3 Product Description
  • 6.4 Serena Cycler
    • 6.4.1 Product Status
    • 6.4.2 Product Description
• 7 M&A Landscape
  • 7.1 Acquisition
    • 7.1.1 Fresenius Medical Care Acquires Memphis Kidney and Dialysis Services
• 8 Appendix
  • 8.1 Methodology
  • 8.2 Secondary Research
  • 8.3 Primary Research
  • 8.4 Models
  • 8.5 Forecasts
  • 8.6 Expert Panels
  • 8.7 Contact US
  • 8.8 Disclaimer
• List of Tables
  • Table 1: Diabetes Mellitus, Estimated Patient Population (‘000's), 2030
  • Table 2: Peritoneal Dialysis Solutions, Revenue ($m), Global, Historic, 2000–2008
  • Table 3: Peritoneal Dialysis Solutions, Revenue ($m), Global, Forecast, 2008–2015
  • Table 4: Peritoneal Dialysis Solutions, Cross Country Analysis, Revenue ($m), 2008
  • Table 5: Incidence of End-Stage Renal Disease (Per Million Population), 2006
  • Table 6: Product Comparison, PD, Top Players
  • Table 7: Peritoneal Dialysis, Pipeline Summary by Territory
  • Table 8: Peritoneal Dialysis, Pipeline Summary by Developmental Stage
  • Table 9: CATHcarry, Product Status
  • Table 10: CATHcarry, Product Description
  • Table 11: CATHcarry, Clincal Trial
  • Table 12: Next Generation APD Cycler, Product Status
  • Table 13: Next Generation APD Cycler, Product Description
  • Table 14: NON PVC CAPD, Product Status
  • Table 15: NON PVC CAPD, Product Description
  • Table 16: Renal Expres, Product Status
  • Table 17: Renal Express, Product Description
  • Table 18: Serena Cycler, Product Status
  • Table 19: Serena Cycler, Product Description
  • Table 20: Fresenius Medical Care Acquires Memphis Kidney and Dialysis Services
• List of Figures
  • Figure 1: End Stage Renal Disease Patients by Therapy Area, Global, 2008
  • Figure 2: Glomerulonephritis, Prevalence, Global, 2008
  • Figure 3: Primary Causes of Kidney Failure
  • Figure 4: Peritoneal Dialysis Solutions, Revenue ($m), Global, Historic, 2000–2008
  • Figure 5: Peritoneal Dialysis Solutions, Revenue ($m), Global, Forecast, 2008–2015
  • Figure 6: Peritoneal Dialysis Solutions, Revenue ($m), Global, Forecast, 2008–2015
  • Figure 7: Peritoneal Dialysis Versus HD – Perception Analysis
  • Figure 8: Peritoneal Dialysis, Penetration (%), 2007
  • Figure 9: Peritoneal Dialysis Solutions, Global, Company Share (%), 2008
  • Figure 10: GlobalData Methodology

Related products